A Johns Hopkins scientist was known for rigorous studies of psychedelics. Was he a true believer?
As historic MDMA decision nears, even J.P. Morgan eyes psychedelic investments
New Research Grants Push Psychedelic Studies Beyond Therapeutics
Investors pile into psychedelic drug start-ups tackling mental health
Massachusetts Lawmakers Approve Psilocybin Bill To Legalize For ‘Therapeutic, Spiritual And Medicinal Purposes’
The Working Woman’s Newest Life Hack: Magic Mushrooms
As investors pile into psychedelics, idealism gives way to pharma economics
What Does Being Sober Mean Today? For Many, Not Full Abstinence.
Idealism gives way to pharma economics as investors rush into psychedelic market
Your employer may be adding another health benefit to its roster: psychedelic drugs